Already have an ACS ID? Log in
Renew your membership, and continue to enjoy these benefits.
Already an ACS Member? Log in here
Choose the membership that is right for you. Discounts will be applied automatically at checkout.
Enjoy these benefits no matter which membership you pick.
Most Popular in Business
CordenPharma has expanded oligonucleotide active pharmaceutical ingredient manufacturing capacity at its Boulder, Colo., plant. The German company, which purchased the site from Roche in 2011, says the facility now can synthesize up to 500 kg of oligonucleotides per year, making it one of the world’s largest oligonucleotide manufacturing sites.
This article has been sent to the following recipient: